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Abstract
Background: Anterior cruciate ligament (ACL) tear is considered a risk factor for osteoarthritis development. The
purpose of our study was to investigate the expression levels of the apoptotic enzyme caspase 3, pro-inflammatory
cytokines interleukin-1β (IL-1β) and interleukin-6 (IL-6) and degrading enzyme matrix metalloproteinase 13 (MMP-13),
all indicative of cartilage degeneration and osteoarthritis development in patients’ chondrocytes after ACL rupture.
Methods: We investigated the correlation between grade of cartilage degradation and time from injury or patients’
age. IL-1β, IL-6 and MMP-13 mRNA expression levels were investigated in normal (n = 4) and chondrocytes from
patients with ACL rupture (n = 33) using real-time polymerase chain reaction (PCR). Moreover, MMP-13 and caspase-3
protein expression levels were evaluated by western blot analysis. Trend analysis and correlation coefficient were
performed to derive the relations between gene expression (MMP13, IL-6, IL-1β) and grading of cartilage defects and
between gene expression (MMP13, IL-6, IL-1β) and patients’ age, respectively.
Results: Correlations were established between grade of cartilage degradation and time from injury. MMP-13, IL-6,
IL-1β and caspase 3 expression levels were significantly upregulated in chondrocytes from ACL-deficient knee
compared to normal. Among the patients with ACL-deficient knees, a significant upregulation of MMP-13 was
observed in patients with ACL-rupture > 18 months from the time of injury to arthroscopy compared to patients with
ACL-injury up to 18 months, whereas IL-6 and IL-1β expression was higher in chondrocytes from patients with more
than 10 months ACL injury compared to those that underwent surgery within the first 10 months after injury. Νο
association was observed between IL-1β, IL-6 and MMP-13 expression levels and cartilage defects or patients’ age.
Conclusion: Our results showed that increased levels of apoptotic, inflammatory and catabolic factors in chondrocytes
are associated with time from injury and could contribute to cartilage degradation and osteoarthritis development
after ACL rupture.
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Background
ACL tear is a common and severe knee injury affecting
mainly young and active population [1]. It has been well
documented that after ACL tear more than 50 % of indi-
viduals show radiographic evidence of osteoarthritis
10–12 years post injury [2, 3]. Potential etiological fac-
tors contributing to osteoarthritis development in the
ACL-deficient knee are patients’ age at time of injury,
time from the onset of injury, obesity, joint malignment,
concomitant presence of an acute meniscal or cartilage
injury, as well as biological factors, such as increase in
catabolic activity of chondrocytes, inflammatory cyto-
kines and proteases activation in the joint after trauma
[4, 5]. It is known that as a response to mechanical forces
and consequent matrix loss, the healthy adult chondrocyte
‘wakes up’ from its low metabolic status and produces a
series of inflammatory mediators, many of which are nor-
mally produced by macrophages in response to injury or
infection. Thus, cytokines, chemokines, reactive oxygen
species, prostaglandins and leukotrienes, increase the
catabolic activity of the chondrocyte, resulting in the re-
lease of proteolytic enzymes, such as aggrecanases and
matrix metalloproteinases, that cause destruction of
cartilage matrix [6, 7]. Moreover, healthy chondrocytes
produce growth factors, such as BMP-2, BMP-7, insulin-
like growth factor 1, and transforming growth factor β,
that stimulate matrix production and inhibit the produc-
tion of proteolytic enzymes. Many of these are stored in
the cartilage bound to matrix proteins and are released
when the matrix is degraded so that they can act locally to
shut down the degradation process [8]. In addition, apop-
totic agents and their inhibitors, interact in a homeostatic
equillibrium in the healthy chondrocyte, as part of the
normal physiology [9].
Animal models of surgically induced osteoarthritis
after ACL transection have been used to clarify the
mechanisms of cartilage degradation after joint injury.
Among key biological processes identified are increased
extracellular matrix (ECM) turnover and remodelling,
angiogenesis, chondrocytes’ apoptosis, subchondral bone
plate rupture, inflammation and cholesterol metabolism,
all of which are associated with human osteoarthritis
pathogenesis [10, 11].
Although several cytokines have been involved in the
aetiology of post-traumatic osteoarthritis, the time-course
changes of cytokines’ levels after ACL injury and their
contribution to cartilage degradation is not clear. It has
been shown that pro-inflammatory cytokines are released
in the synovial fluid in patients with acute or chronic ACL
injury and are involved in MMPs stimulation and initi-
ation of cartilage degradation [12–15]. Increased protein
levels of MMP-3 and tissue inhibitor of metalloproteinases
1 (TIMP-1), as well as elevated proteoglycan and type II
collagen fragments have been observed in the synovial
fluid of patients following an ACL or meniscal tear from
day 1 up to 20 years post injury [16, 17], suggesting an un-
balanced degrading process, that can significantly increase
the risk of osteoarthritis.
Besides inflammatory cytokines and degrading en-
zymes, apoptosis has also been demonstrated to be in-
volved in osteoarthritis development after mechanical
injury in animal models and in human joints, evidenced
by the activation of caspases, enzymes that regulate and
execute apoptosis [18–20]. Chondrocytes’ death, mostly
through apoptotic mechanisms contributes to matrix
degradation due to reduction of functional cells that are
required to repair and maintain the extracellular matrix.
The purpose of the present study was to investigate
molecular changes in apoptotic enzymes, inflammatory
cytokines and metalloproteinases indicative of cartilage
degeneration and osteoarthritis development in patients
after ACL injury. For this reason, we tested the expres-
sion levels of representative molecules for the above pro-
cesses, such as caspase 3, a key molecule for apoptotic
mechanisms, IL-1β and IL-6, the basic inflammatory
catabolic cytokines and MMP-13, the major catabolic
enzyme of cartilage degradation.
Methods
Patients and cartilage samples
Articular cartilage samples were obtained from 33
patients undergoing knee arthroscopy following ACL
rupture (mean age 25.25 years ± 8.14). Αll samples were
obtained from a predetermined non-weight bearing area
of the lateral femoral condyle, with the same instrument
(arthroscopic spoon) in order to ensure the same sample
dimension. Standard arthroscopic portals including an
anterolateral and an anteromedial portal were used in all
cases. A thorough evaluation of the joint was performed
in every case using the anterolateral portal as viewing por-
tal and the anteromedial portal as a working portal (using
a probe). ACL rupture was assessed and confirmed
arthroscopically using a probe. During ACL reconstruc-
tion, the entire articular surface was arthroscopically visu-
alized and articular cartilage lesions were graded (0–4)
according to the ICRS classification [21]. The inclusion
criteria of patients were: a. ACL rupture in the affected
knee established both clinically and with MRImaging, b.
no previous knee surgery, c. skeletal maturity and d. no
other ligamentous injury or lower limp malalignment. The
exclusion criteria were as follows: (a) age more than 55 or
less than 15 years, (b) previous major injury in the lower
extremities and (c) rheumatic diseases or psychosocial dis-
orders. Normal articular cartilage was obtained from 4
young healthy individuals (mean age 27.25 years ± 4.11),
undergoing fracture repair surgery around the knee joint
and above knee amputations after crush injuries. Written
informed consent was obtained from all individuals of the
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study. The study protocol conformed to the ethical guide-
lines of the 1975 Declaration of Helsinki as reflected in a
priori approval by the Local Ethical Committee of the
University Hospital of Larissa.
Primary cultures of human articular chondrocytes
Articular cartilage was dissected and subjected to sequen-
tial digestion with 1 mg/ml pronase and 1 mg/ml collage-
nase P (Roche Applied Science, Mannheim, Germany).
Chondrocytes were counted and checked for viability
using trypan blue staining. More than 95 % of the cells
were viable after isolation. Isolated chondrocytes from
individual specimens were separately cultured with
Dulbecco’s Modified Eagles Medium/Ham’s F-12
(DMEM/F-12) (GIBCO, Life Technologies, Paisley,
UK) plus 5 % fetal bovine serum (FBS, Invitrogen,
Life Technologies, Paisley, UK) at 37οC under a hu-
midified 5 % CO2 atmosphere until reaching conflu-
ence for 4–6 days. Cultured chondrocytes were then
harvested by trypsinization and were used for RNA
and protein extraction.
RNA extraction and quantification of mRNA expression
Total cellular RNA was extracted from cultured chondro-
cytes using Trizol reagent (Invitrogen, Life Technologies,
Paisley, UK). Preservation of 28S and 18S ribosomal RNA
(rRNA) species was used to assess RNA integrity. All the
samples included the study were with prominent 28S and
18S rRNA components. The yield was quantified spectro-
photometrically. Transcription of 1 μg RNA to cDNA was
performed using SuperScript III reverse transcriptase
(Invitrogen, Life Technologies, Paisley, UK) and random
primers (Invitrogen, Life Technologies, Paisley, UK).
Quantification of MMP-13, IL-6 and IL-1β mRNA expres-
sion was performed by real-time PCR (ABI 7300, Applied
Biosystems, Foster, CA). The oligonucleotide primers used
for MMP-13, IL-6 and IL-1β amplification are showed in
Table 1. To quantify the relative expression of each gene,
Ct values were normalized against the endogenous refer-
ence (ΔCt = Ct target – Ct GAPDH) and were compared
with a calibrator using the ΔΔCt method (ΔΔCt = ΔCt
sample – ΔCt calibrator).
Protein extraction and Western blot analysis
Chondrocytes were lysed using RIPA buffer containing
10 mM Tris (pH 7.5), 150 mM NaCl, 1 % Triton X-100,
1 % Sodium Deoxycholated, 0.1 % SDS, 1 mM EDTA,
and a cocktail of protease inhibitors. Protein concentra-
tion was quantified using the Bio-Rad Bradford protein
assay (Bio-Rad Protein Assay, BioRad, Hercules, CA,
USA) with bovine serum albumen as standard. Cell ly-
sates from chondrocytes were electrophoresed and sepa-
rated on 10 % acrylamide gels and transferred to PVDF
membranes (Millipore, Billerica, MA, USA). The mem-
brane was probed with anti-MMP-13 (Abcam, Life
Technologies, Paisley, UK) and anti-caspase 3 (Santa
Cruz, Santa Cruz Biotechnology, CA, USA) and signal
was detected using anti-rabbit immunoglobulin IgG con-
jugated with horseradish peroxidase (1:10000 dilution)
(Invitrogen, Life Technologies, Paisley, UK). The results
were normalized using anti-β-actin polyclonal antibody
(1:3000 dilution) (Sigma-Aldrich, Missouri, USA). PVDF
membranes were then exposed to photographic film and
western blot bands from several different blots were
quantified using the NIH Scion Image according to the
software’s guidelines.
Statistical analysis
Data were analysed by the non-parametric Kruskal-Wallis
test using the SPPS 20 software. Where significant vari-
ance was demonstrated, differences between individual
groups were then determined using Mann–Whitney 2-
tailed U test. Trend analysis (Jonckheere test) was used to
derive the relations between gene expression (MMP13,
IL-6, IL-1b) and grading of cartilage defects and to esti-
mate the significance of the relations. Correlation coeffi-
cients were calculated by Spearman rank correlation.




All cartilage samples (33 from patients with ACL injury
and 4 cartilage from healthy individuals) were success-
fully cultured and chondrocytes were obtained. We
therefore used for all experiments cultured chondrocytes
and not fresh tissue, as we have previously reported that
there are no differences in genes’ and protein expression
levels between cultured and chondrocytes obtained from
fresh tissue [22].
All normal cartilage samples from healthy individuals
(n = 4) and 6 cultured cartilage samples taken at random
from the 33 patients with ACL injury were used as indi-
cative ones for the detection of caspase 3 and MMP-13
protein expression by Western blot analysis. For the
evaluation of IL-1β, IL-6 and MMP-13 mRNA levels, all
normal cartilage samples (n = 4) and 28 random cartilage
samples from the 33 patients with ACL injury were used.
Moreover, all experiments regarding mRNA (IL-1β,
IL-6 and MMP-13) and protein levels (caspase 3 and
Table 1 Oligonucleotide primers used in real-time PCR assay
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MMP-13) were evaluated at 4 different time periods
(6, 10, 18 and 24 months). Accordingly, we separated
all cartilage samples after ACL injury in 2 groups for
each time period. More specifically;
Group A: ACL injury < 6 months and >6 months
Group B: ACL injury < 10 months and >10 months
Group C: ACL injury < 18 months and >18 months and
Group D: ACL injury < 24 months and >24 months.
Articular cartilage damage, time from ACL injury and
patients’ age
The number of patients included in the study and the
ICRS grading is shown in Fig. 1a. Correlation coeffi-
cients were calculated for ACL injury to determine
possible associations between grade of cartilage degrad-
ation and time from injury. Our results showed that the
time from injury to arthroscopy was significantly greater
in patients with damaged articular cartilage (ICRS grades
I, II, III and IV) (28.36 ± 4.4 months) compared to pa-
tients with normal articular surfaces (ICRS grade 0)
(12.5 ± 3.2 months) (p < 0.05) (Fig. 1b). Moreover, the
mean age of patients in the different ICRS grades is
shown in Fig. 1c. No correlation was observed between
patient’s age at the time of injury and grade of cartilage
damage (ICRS grade 0, I, II, III and IV).
Caspase 3 expression in ACL-deficient knees
To investigate the role of chondrocyte apoptosis in articu-
lar cartilage chondrocytes after ACL-injury, we evaluated
Fig. 1 Correlation between articular cartilage damage and time from ACL injury or patients’ age. a The number of patients with ACL rupture
based on the ICRS classification. b Correlation between average time from injury with cartilage damage (ICRS grade I, II, III and IV) and those with
no chondral lesions (ICRS grade 0) and c Grade of chondral damage versus mean patients’ age
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caspase 3 protein expression levels and found a significant
increase of caspase 3 expression in chondrocytes of
patients with ACL-rupture compared to normal chondro-
cytes (Fig. 2a, b) (p < 0.05). No association was found be-
tween apoptosis and time of injury, as we observed no
difference in caspase 3 expression in chondrocytes from
patients with more than 18 months ACL injury compared
to those that underwent surgery within the first 18 months
after injury (Fig. 2c, d).
IL-1β and IL-6 expression in ACL-deficient knees
IL-1β and IL-6 mRNA expression levels were found to
be upregulated in chondrocytes isolated from ACL-
deficient knees compared to normal chondrocytes
(Fig. 3a, b) (p < 0.05). Furthermore, we found an associ-
ation between IL-1β and IL-6 mRNA expression levels
and time course (time since trauma) after ACL injury, as
we observed a significant upregulation of IL-1β and IL-6
expression in patients with ACL-rupture > 10 months
from time of injury to arthroscopy compared to patients
with ACL-injury up to 10 months (Fig. 3c, d) (p < 0.05).
As IL-1β and IL-6 contribute to the acute inflamma-
tory phase after ACL injury, the patient population
with ACL rupture up to 12 months was divided into
3 groups: group A: 1-4 months (n = 8), group B: 5-8
months (n = 5), group C: 9–12 months (n = 3).
Although there were no significant differences in IL-
1β and IL-6 expression levels among the different
groups, we observed a trend of increase of IL-6 ex-
pression in the 3rd group (9–12 months) compared to
the other groups (Fig. 3e). No association was found be-
tween IL-1β and IL-6 mRNA expression levels and cartil-
age defects (p = 0.899 IL-1β vs cartilage defects, p = 0.737
IL-6 vs cartilage defects) or patients’ age (p = 0.983 IL-1β
vs patients’ age, p = 0.967 IL-6 vs patients’ age).
MMP-13 expression in chondrocytes after ACL injury
To provide evidence that extracellular matrix degrad-
ation observed after ACL injury is mediated by stimula-
tion of catabolic enzymes, we evaluated MMP-13
expression levels in normal chondrocytes and in chon-
drocytes from patients with ACL rupture. We found sig-
nificant upregulation of MMP-13 mRNA and protein
expression levels in chondrocytes isolated from ACL-
deficient knees compared to normal chondrocytes
(Fig. 4a, b, c) (p < 0.05). Moreover, among patients with
ACL-deficient knees, we observed significant upregula-
tion of MMP-13 mRNA and protein expression in pa-
tients with ACL-rupture > 18 months from time of
injury to arthroscopy compared to patients with ACL-
injury up to 18 months (Fig. 4d, e) (p < 0.05). No asso-
ciation was found between ΜΜP-13 mRNA expression
Fig. 2 Caspase 3 expression in ACL-deficient knees. a and b Representative western blot of Caspase 3 protein expression in cultured normal
chondrocytes and chondrocytes from patients with ACL rupture and a bar graph showing relative Caspase 3 protein expression normalized to
β-actin in normal (n = 4) and ACL rupture chondrocytes (n = 6). (Error bars = standard errors, * p < 0.05). c and d Representative western blot of
Caspase 3 expression in chondrocytes from patients with more than 18 months ACL injury compared to patients with ACL-injury up to 18 months
and normal chondrocytes. A bar graph showing relative Caspase 3 protein expression normalized to β-actin in normal (n = 3), ACL-injury up
to 18 months (n = 3) and ACL rupture more than 18 months chondrocytes (n = 3). (Error bars = standard errors, * p < 0.05 versus normal, NS
ACL < 18 months versus ACL > 8 months)
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levels and cartilage defects (p = 0.900) or patients’ age
(p = 0.306).
Discussion
Although significant differences exist between patient
populations from different ethnic origins followed in re-
vision ACL cohorts [23], it is well established that both
reconstruction and conservative treatment after ACL
rupture are associated with increased risk for osteoarth-
ritis development [4, 24, 25]. Biochemical changes in
addition to altered joint biomechanics are among major
contributing factors to post traumatic disease process
[26], however, the mechanisms involved in articular car-
tilage degradation after injury are not well understood.
In the present study, we sought to investigate molecular
changes in chondrocytes indicative for cartilage degener-
ation and osteoarthritis development following ACL
rupture.
We demonstrated a strong correlation between time
from ACL injury to arthroscopy and severity of chondral
damage. We observed that patients with more than two
years ACL-injury presented chondral changes and high-
grade cartilage lesions due to the long duration of knee
instability, whereas no cartilage degeneration was ob-
served in patients with ACL-injury up to 12 months,
pointing to the influence of time from injury on osteo-
arthritic changes in the ACL deficient knee. This finding
is in agreement with previous studies reporting an asso-
ciation among the progressive radiographic evidence of
cartilage damage, the time of the reconstruction of ACL-
Fig. 3 IL-1β and IL-6 expression in ACL-deficient knees. a and b Quantitative IL-1β and IL-6 mRNA expression in normal chondrocytes and chondrocytes
from patients with ACL rupture (Error bars = standard errors, * p< 0.05). c and d Quantitative IL-1β and IL-6 mRNA expression in chondrocytes from
patients with more than 10 months ACL injury compared to those that underwent surgery within the first 10 months after injury and normal chondrocytes
(Error bars = standard errors, * p< 0.05). e Quantitative IL-1β and IL-6 mRNA expression in chondrocytes from patient with ACL rupture up to 12 months
(group A: 1–4 months, group B: 5–8 months, and group C: 9–12 months
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Fig. 4 MMP-13 expression in chondrocytes after ACL injury. a Quantitative MMP-13 mRNA expression in cultured normal chondrocytes and
chondrocytes from patients with ACL rupture. GAPDH was used for normalization of the real-time PCR data. (Error bars = standard errors,
* p < 0.05). b and c Representative western blot of MMP-13 protein expression in cultured normal chondrocytes and chondrocytes from
patients with ACL rupture and a bar graph showing relative MMP-13 protein expression normalized to β-actin in normal (n = 4) and ACL
rupture chondrocytes (n = 6). (Error bars = standard errors, * p < 0.05). d Quantitative MMP-13 mRNA expression in chondrocytes from
patients with more than 18 months ACL injury compared to those that underwent surgery within the first 18 months after injury and normal
chondrocytes (Error bars = standard errors, * p < 0.05). e and f Representative western blot of MMP-13 expression in chondrocytes from
patients with more than 18 months ACL injury compared to patients with ACL-injury up to 18 months and normal chondrocytes. A bar
graph showing relative MMP-13 protein expression normalized to β-actin in normal (n = 3), ACL-injury up to 18 months (n = 3) and ACL
rupture more than 18 months chondrocytes (n = 3). (Error bars = standard errors, * p < 0.05)
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injury and OA development in the ACL-deficient knee
[27–31].
Joint instability after injury results in abnormal loading
forces leading to changes in chondrocytes’ metabolism
and cartilage degradation [32]. Chondrocytes’ apoptosis
is considered to play an important role in articular car-
tilage disruption, as chondrocytes are responsible for
maintaining the function and homeostasis of cartilage
[33]. We demonstrated excessive activation of apoptotic
mechanisms after chronic ACL injury evidenced by the
increased levels of caspase 3; however, this activation
was not associated with time from injury. Previous stud-
ies have identified chondrocyte death following impact
to articular cartilage [34–36], while it has been shown
that the superficial zone of cartilage is the most suscep-
tible to cell death after mechanical injury [37]. Mechan-
ical injury induces chondrocytes’ apoptosis and release
of glycosaminoglycns (GAGs) from the matrix [38] sug-
gesting the inhibition of progressive increase in apop-
totic cells as a therapeutic target. However, whether
chondrocytes’ apoptosis is a cause or a result of cartilage
degeneration after injury and subsequent osteoarthritis
is hotly contested.
It has been suggested that inflammatory cytokines are el-
evated in peripheral blood and/or synovial fluid following
joint injury and that their levels may be correlated with se-
verity of cartilage damage in osteoarthritis [15, 39–41]. To
investigate the role of inflammatory cytokines in chondro-
cytes after ACL rupture, we evaluated IL-1β and IL-6 ex-
pression levels in chondrocytes isolated from patients with
ACL-deficient knee and found significantly higher L-1β and
IL-6 mRNA expression levels compared to normal chon-
drocytes. Moreover, we observed that differences in cyto-
kine expression were correlated to time of injury, as IL-1β
and IL-6 expression levels were higher in patients with
more than 10 months ACL injury, suggesting the involve-
ment of cytokines imbalance in the progressive cartilage
degradation over time after ACL injury. Marks et al. dem-
onstrated difference in cytokine profiles in synovial fluid be-
tween normal and injured knees and this difference varied
based on the severity of chondral damage, which was asso-
ciated with time from injury [15]. In addition previous stud-
ies demonstrated increased release of IL-1 and IL-6, in
peripheral blood, as early as 1 to 6 h after surgery in the
acute phase of inflammation [39, 40]. In acute anterior cru-
ciate ligament injured knee the highest levels of inflamma-
tory cytokines, IL-1β, IL-6, IL-8 and IL-10 were detected
intra-articularly within few weeks or months after injury
and subsequently all inflammatory cytokines decreased to
levels observed in chronic arthritis [13, 42, 43]. This finding
can explain why we did not observe differences in IL-1β
and IL-6 expression levels in the group of patients with
ACL deficiency up to 12 months, as patients in our study
had subchronic and chronic ACL-injury and not acute.
Moreover, a recent study demonstrated that two
blockers of catabolic processes stimulated by cyto-
kines, IGF-1 and Dex, inhibited the cytokine-mediated
cartilage degradation in adult human cartilage provid-
ing a new approach for treatment of early- stage OA
associated with joint injury [44].
The balance of tissue remodelling and synthesis is con-
trolled by matrix metalloproteinases (MMPs) and their
natural inhibitors (TIMPs) and it is widely accepted that
the release of extracellular matrix-degrading enzymes is
an important mechanism in post-traumatic cartilage
damage [45]. We demonstrated significant upregulation
of MMP-13 expression in injured chondrocytes and this
upregulation was associated with time from injury, sug-
gesting the contribution of the catabolic enzyme, MMP-
13, in cartilage degradation during chronic ACL-injury.
MMP-13 is a collagenase and has a predominant role in
osteoarthritis due to its contribution to collagen degrad-
ation. MMP-13 also degrades the proteoglycan molecule,
aggrecan, having a dual role in matrix destruction. Frag-
ments of extracellular matrix that are generated by
extracellular matrix-degrading enzymes stimulate further
production of pathogenetic mediators [19], whereas
chondrocytes have been demonstrated to express in-
creased levels of MMP-1, MMP-3, MMP-8, MMP-9,
MMP-13 and ADAMTS-5 after mechanical impact in-
jury [46, 47]. In a recent study Haslauer et al. reported
that upregulation of genes coding for proteins capable of
degrading cartilage ECM, in adolescent minipigs, is ob-
served within the first few days after ACL injury and this
response is seen not only in chondrocytes, but also in
cells in the synovium and ligament [48].
We must acknowledge a limitation of the present study,
which is the small number of cartilage samples from indi-
viduals after ACL injury and from healthy ones.
Conclusion
We demonstrated, for the first time, that chondrocytes
after ACL injury produce apoptotic, inflammatory and
catabolic factors and that increased levels of these fac-
tors are associated with time from injury contributing
to cartilage degradation. Our data provide some indi-
cation that chondrocytes after ACL injury undergo
molecular changes resembling those that take place in
osteoarthritis, suggesting that factors responsible for
articular cartilage homeostasis combined with appro-
priate surgical treatments may yield more effective
therapies for post-traumatic osteoarthritis.
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